Literature DB >> 26336088

Psychometric Properties of the Problem Areas in Diabetes (PAID) Instrument in Singapore.

Kavita Venkataraman1, Luor Shyuan Maudrene Tan1, Dianne Carrol Tan Bautista2, Konstadina Griva3, Yasmin Laura Marie Zuniga4, Mohamed Amir3, Yung Seng Lee5, Jeannette Lee1, E Shyong Tai6, Eric Yin Hao Khoo4, Hwee Lin Wee7.   

Abstract

BACKGROUND: Emotional distress is an important dimension in diabetes, and several instruments have been developed to measure this aspect. The Problem Areas in Diabetes (PAID) scale is one such instrument which has demonstrated validity and reliability in Western populations, but its psychometric properties in Asian populations have not been examined.
METHODS: This was a secondary analysis of data from patients with Type 2 diabetes mellitus recruited through convenience sampling from a diabetes specialist outpatient clinic in Singapore. The following psychometric properties were assessed: Construct validity through confirmatory factor analysis (CFA) and Rasch analysis, concurrent validity through correlation with related scales (Kessler Psychological Distress Scale, Diabetes Health Profile-psychological distress, Audit of Diabetes Dependent Quality of Life), reliability through assessment of internal consistency and floor and ceiling effects, and sensitivity by estimating effect sizes for known clinical and social functioning groups.
RESULTS: 203 patients with mean age of 45±12 years were analysed. None of the previously published model structures achieved a good fit on CFA. On Rasch analysis, four items showed poor fit and were removed. The abridged 16-item PAID mapped to a single latent trait, with a high degree of internal consistency (Cronbach ɑ 0.95), but significant floor effect (24.6% scoring at floor). Both 20-item and 16-item PAID scores were moderately correlated with scores of related scales, and sensitive to differences in clinical and social functioning groups, with large effect sizes for glycemic control and diabetes related complications, nephropathy and neuropathy.
CONCLUSION: The abridged 16-item PAID measures a single latent trait of emotional distress due to diabetes whereas the 20-item PAID appears to measures more than one latent trait. However, both the 16-item and 20-item PAID versions are valid, reliable and sensitive for use among Singaporean patients with diabetes.

Entities:  

Mesh:

Year:  2015        PMID: 26336088      PMCID: PMC4559380          DOI: 10.1371/journal.pone.0136759

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The Problem Areas in Diabetes (PAID) instrument was developed to measure emotional distress in people with diabetes. It is a 20-item scale consisting of emotional problems commonly reported in type 1 and type 2 diabetes mellitus, and has been found to be a valid and reliable scale in Western populations[1-3]. It has also been found to be responsive, that is, able to detect change when used in intervention studies[4]. Several language versions of the scale have also been tested and found to be valid and reliable for use in the specific populations[3, 5–8]. The original scale was constructed as a single domain structure, with an underlying emotional distress factor being related to all the items[1]. Subsequently, other researchers have found conflicting results, with some confirming the original single-factor structure[2, 8], and others identifying multiple sub-dimensions[3, 6, 7]. Type 2 diabetes mellitus is becoming an important public health problem in Singapore, with a prevalence of 11.3% in 2010[9], and a projected prevalence of 15% by 2050[10]. Several patient reported outcome measures have been examined for their validity in this patient population. As emotional distress is an important dimension in diabetes and affects not only the patient’s experience of disease and care, but also their compliance with treatment and lifestyle regimens[11, 12], it will be useful to examine the psychometric properties of the PAID scale in this context. While a Chinese translation of the PAID instrument has been validated in Taiwan and found to have a single-factor structure[8], the original English version has not been similarly examined in any Asian context. In this study, we attempt to evaluate the validity, both construct and concurrent, reliability and sensitivity of PAID in a group of Singaporean patients with Type 2 diabetes mellitus.

Methods

This is a secondary analysis of the baseline data of a prospective longitudinal study on outcomes in patients with diabetes mellitus (PEAQ DM). The study recruited patients aged between 21 and 65 years old, who were diagnosed with diabetes (both Type 1 and Type 2) for at least one year. The upper age limit was set at 65 years as older people are more likely to have other associated comorbid conditions that could affect the level of emotional distress. Patients were recruited at least one year post-diagnosis to avoid confounding of findings by any short-term increase in anxiety and stress due to diabetes diagnosis, as suggested by previous research[13, 14]. Patients undergoing routine clinic visits at the specialist Endocrinology outpatient clinic of the National University Hospital were selected by convenience sampling at the clinic waiting area from 2011 to 2012. Only English literate patients were included in the study. Patients were excluded if there was self-reported or documented unstable and ongoing treatment of heart, kidney, liver and psychiatric conditions. This study was approved by the National Healthcare Group Domain Specific Review Board (Protocol No.: 2011/02018), and written informed consent obtained from all patients prior to participation. Only patients with type 2 diabetes were included in this analysis.

Demographics

Demographic details such as age, gender, ethnicity, educational status, marital status, type of housing and household income were collected using self-administered questionnaires. Ethnicity was classified as Chinese, Malay, Asian Indian or Others. Marital status was classified as “never married”, “currently married” or “separated/divorced/widowed”. Education level was categorized into <7, 7–10 and >10 years of schooling. Housing was categorized into Housing Development Board flat (HDB) of 4 rooms or smaller, 5-room HDB/ Executive flat and private housing, representing increasing socioeconomic status. Monthly household income was categorised as less SGD 4000, SGD 4000–7999, and SGD 8000 and above, where SGD 7999 corresponds to the median household income[15].

PAID

PAID is a self-administered 20-item scale. Each item is scored from 0 (not a problem) to 4 (serious problem). The sum of all item scores multiplied by 1.25 gives the total PAID score, which ranges from 0 to 100, higher scores reflecting greater emotional distress. A score of 40 or above is indicative of severe emotional distress [16].

Other psychological scales

The Kessler Psychological Distress Scale (K10) is a 10-item global measure of distress, with questions on anxiety and depressive symptoms in the past four weeks. All items are scored on a scale of 1 (none of the time) to 5 (all of the time). The sum of all item scores yields the total score, which has a range of 10 to 50[17]. The Diabetes Health Profile consists of 18 items and three sub-scales: psychological distress (DHP-PD), barriers to activity and disinhibited eating. The 6-item DHP-PD sub-scale was used to correlate PAID scores in this analysis. Each item was scored on a scale of 0 to 3. The sum of the 6 items divided by 18 and then multiplied by 100, gave the DHP-PD sub-scale score[18]. The Audit of Diabetes Dependent Quality of Life (ADDQoL) is a 19-item scale measuring diabetes-specific quality of life. Respondents rate the impact of diabetes on a domain from -3 (maximum negative impact) to +3 (maximum positive impact), and the importance of that domain on a scale of 0 (not important) to 3 (very important). The impact and importance ratings are multiplied to give the score for that domain. These scores are averaged across applicable domains to derive the overall score[19]. Scores range from -9 to +3, with lower scores reflecting poorer QoL. All scales were scored according to their respective manuals.

Known groups

Clinical

Glycemic control was determined by glycated haemoglobin (HbA1c), and classified as good control (HbA1c ≤ 7.0%) and poor control (HbA1c > 7.0%). HbA1c was retrieved from the electronic medical record and is routinely measured at the National University Hospital Referral Laboratory, which is accredited by the College of American Pathologists using an assay accredited by the National Glycoprotein Standardization Program with controls traceable to the Diabetes Control and Complications Trial (DCCT). Medical history of co-morbidities and complications (cardiovascular disease, retinopathy, nephropathy, peripheral vascular disease, cerebrovascular disease and anaemia) were captured through a combination of self-report and electronic medical record search.

Social functioning

Patients were asked to rate their effectiveness at work and outside of work on a scale of 0–10. This was dichotomised into effective (6–10) and not effective (0–5) for both at work and outside. Satisfaction with family life was recorded on a single-item with Likert scale ranging from poor to excellent. The scores were subsequently collapsed into not satisfied (poor and fair) and satisfied (good, very good, excellent) with family life.

Statistical analysis

Means and SDs were used to describe continuous variables, while counts and proportions were used for categorical variables. For purposes of analysis, age was stratified into those below 45 years of age and those 45 years and above, 45 being the mean age of the group. All analyses were performed using STATA version 11 (StataCorp LP), except calculation of effect sizes for sensitivity analysis, which were computed in MS Excel.

Construct validity

Construct validity is the degree to which a test measures what it is designed to measure. Factor analysis is an accepted method to assess construct validity[20]. We used confirmatory factor analyses (CFA) based on all published factor structures[3, 5–7, 21–23]. A comparative fit index (CFI) and Tucker Lewis index (TFI) of more than 0.9 were taken as indicative of a good fit. Interestingly, none of the models based on previously published factors achieved a good model fit. Only the single factor structure and Miller et al’s[22] two-factor structure achieved model convergence, with CFI and TFI of 0.76 and 0.74, and 0.79 and 0.76, respectively. As such, we used Rasch analysis [24] to evaluate if the 20 PAID items measure a single latent variable (diabetes-related emotional distress). The items were recoded into dichotomous variables with response levels 0 and 1 combined as “No or mild problem” and response levels 2 to 4 combined as “Moderate to severe problem” to facilitate Rasch analysis. As the latent trait does not follow a normal distribution, conditional maximum likelihood was used to estimate the difficulty parameter. Items with Infit or Outfit values exceeding +/-2 were regarded to have poor model fit and were excluded from the model. Infit relates to unexpected behaviour affecting responses to items that are near the person ability level whereas outfit relates to unexpected behaviour affecting responses to items that are further away from the person ability level. The analysis was repeated with the misfitting items removed until there was no more item with infit or outfit value exceeding +/-2. The item-person map was generated to evaluate if the difficulty range of the items adequately covered the ability range of the persons. In this case, item difficulty refers to the level of diabetes-related emotional distress needed for an individual to endorse a particular item while person ability refers to the level of diabetes-related emotional distress experienced by an individual.

Concurrent validity

16-item PAID scores were compared with scores of other scales measuring similar or related constructs: K10, DHP-PD and ADDQOL using Spearman correlations.

Reliability

Internal consistency of the scale was assessed by Cronbach’s alpha coefficient[25]. The percentage of respondents scoring at the floor (total score = 0) and ceiling (total score = 100) was also determined. A floor (ceiling) effect was defined as being present if >15% of the subjects scored at the minimum (maximum) level respectively[26].

Sensitivity

Sensitivity is the ability of an instrument to detect a difference between patient sub-groups that is both clinically relevant and statistically significant[27-29]. Sensitivity was determined by computing the effect size (difference in mean scores/ pooled standard deviation) for the known demographic, clinical and social functioning groups as described above. Effect sizes of 0.2, 0.5 and 0.8 were considered small, moderate and large, respectively[30]. One-way ANOVA was used to test for significant differences in PAID scores between these sub-groups.

Results

Of the 578 patients approached for participation, 185 declined, while another 89 did not meet the inclusion criteria. Of the 304 patients recruited, 82 had type 1 diabetes. Five of the 222 patients with type 2 diabetes did not complete study procedures, and therefore data was available for only 217 patients. Of these, 10 had PAID items missing while 4 had DHP-PD items missing, and were excluded. The remaining 203 patients were included in the analysis. The mean age of the patients was 45 years, with 64% (130) men (Table 1). The majority were Chinese, with over seven years of education, and married. Mean PAID score was 28.8(±21.9), with 65 (32%) reporting a PAID score of 40 or above, denoting severe emotional distress. The difficulty range of the items provided adequate coverage of the ability range of the persons (Fig 1).
Table 1

Characteristics of participants in the study (N = 203).

 CharacteristicN%
Gender
    Male13064.0
    Female7336.0
Ethnicity 
    Chinese10350.7
    Malay2311.3
    Indian5627.6
    Others2110.3
Education 
    < 7 yrs158.0
    7–10 yrs6534.6
    > 10 yrs10857.5
Marital status 
    Single4121.9
    Married12667.4
    Divorced/Widowed2010.7
Housing type 
    1–4 room HDB8847.8
    5 room HDB/ exec6133.2
    private housing3519.0
Co-morbidities (yes) 
    Retinopathy2515.6
    Cardiovascular Disease2512.3
    Nephropathy169.4
    Neuropathy148.3
    Cerebrovascular Disease125.9
    Anemia127.1
    PVD63.4
Mean(SD) 95% CI
Age45 (11.9)43.7–47
Mean HbA1c8.3 (1.9)8.0–8.5
Pyschological Distress scales
    PAID28.8 (21.9)25.8–31.8
    K1019.4 (6.9)18.4–20.3
    DHP-PD21.3 (23.2)18.2–24.4
    ADDQoL-2.9 (2.2)-3.2–-2.6
Fig 1

Item-person map illustrating the distribution of item difficulty along the y-axis and person ability along the x-axis.

Construct validity

Four items (Not having clear and concrete goals for diabetes care, Feeling depressed when thinking about living with diabetes, Feeling that diabetes is taking up too much of mental and physical energy every day and Feeling that friends and family are not supportive of diabetes management efforts) were removed because of misfit (Table 2). The remaining 16 items, henceforth referred to as 16-item PAID, provided good coverage of item difficulty. 69 out of 203 subjects (34%) achieved full scores on the 16-item PAID.
Table 2

Item difficulty and fit statistics from Rasch analysis.

ItemsDifficulty ParametersStd. Err.R1cdfp-valueStandardized OutfitStandardized InfitU
PAID1. no clear goals for care -0.525 0.310 22.447 2 0 3.846 4.720 4.110
PAID2. discouraged with treatment plan0.3970.3162.03320.3618-1.194-0.600-1.185
PAID3. feel scared about living with diabetes-0.5250.3101.98420.3709-1.830-1.663-1.564
PAID4. uncomfortable social situations relating to diabetes0.5000.3171.00020.6066-0.882-0.750-0.481
PAID5. feel deprived about food0.0980.3130.51020.77480.2820.4370.472
PAID6. feel depressed about living with diabetes 0.197 0.314 5.139 2 0.0766 -2.036 -2.630 -1.317
PAID7. not knowing if moods related to diabetes-0.0490.3120.51020.7750.9470.5961.414
PAID8. feel overwhelming by diabetes0.3470.3155.71420.0575-1.865-1.476-2.199
PAID9. worry about low blood sugar reactions0.0980.3132.34820.30910.9881.7790.949
PAID10. feel angry about living with diabetes0.8150.3212.16520.3387-1.677-1.518-1.019
PAID11. feel constantly concerned about eating-0.2410.3111.41420.49320.1921.2030.346
PAID12. worrying about the future-2.3070.3221.38820.49960.2270.4131.427
PAID13. feeling guilty when off track with diabetes management-1.5510.3130.64320.72520.1371.0551.714
PAID14. not accepting diabetes0.6030.3182.14420.3423-1.732-1.741-0.992
PAID15. feel unsatisfied with physician2.2470.3491.29520.52340.179-0.8220.294
PAID16. feel that diabetes takes up too much energy 0.397 0.316 5.533 2 0.0629 -2.382 -2.244 -1.742
PAID17. feel alone with diabetes1.0330.3242.24720.3251-0.754-1.828-1.006
PAID18. feel family not supportive of diabetes management efforts 2.247 0.349 5.564 2 0.0619 0.244 2.226 1.558
PAID19. coping with diabetes complications-0.1930.3113.58620.16650.5361.3931.232
PAID20. feel burned out by effort needed to manage diabetes0.000.7.05720.0294-1.490-1.683-0.636

R1c test R1c = 73.481 38 0.0005.

Andersen LR test Z = 77.248 38 0.0002.

Items with infit or outfit statistics exceeding +/-2 are in bold.

R1c test R1c = 73.481 38 0.0005. Andersen LR test Z = 77.248 38 0.0002. Items with infit or outfit statistics exceeding +/-2 are in bold.

Concurrent validity

16-item PAID scores were moderately correlated with K10 (rho 0.53, p <0.001), DHP-PD (rho 0.56, p <0.001) and ADDQoL (rho -0.54, p <0.001).

Reliability

Cronbach’s alpha was 0.95 for the 16-item PAID, indicating a high degree of internal consistency. There was a significant floor effect using the revised scale, with 24.6% of the respondents scoring at the floor. 9.4% scored at the ceiling. This was in contrast to the original scale where there were no significant floor or ceiling effects, with 5.4% of respondents scoring at the floor and none at the ceiling.

Sensitivity

The PAID scale did not distinguish between patients from different socio-demographic groups, except for education, household income and housing type, which had small to moderate effect sizes (Table 3). On the other hand, the scale was able to discriminate well between clinical groups, with moderate to large effect sizes for glycemic control and complication groups. The largest effect sizes were for glycemic control (1.07 for HbA1c > 8% with HbA1c <7% as reference), and nephropathy (1.02) and neuropathy (0.8) compared to those with no complications. PAID was also able to distinguish between those with greater effectiveness at work and outside, but the effect sizes were small to moderate.
Table 3

Comparison of 16-item PAID scores across known demographic, clinical and social functioning groups.

Variable 1 NMeanStd. Dev.Effect size P 2
Clinical groups
Glycemic control
    Hba1c = <7.0503.14.3
    Hba1c 7–8634.85.40.350.257
    Hba1c>8.0908.75.7 1.07 <0.001
Complications
    No complications304.84.9
    Retinopathy257.35.1 0.49 0.043
    Cardiopathy257.96.2 0.56 0.052
    Nephropathy1610.05.5 1.02 0.002
    Neuropathy148.95.7 0.80 0.013
    Cerebro-vascular problems127.86.30.570.146
    Anaemia125.34.80.100.701
Social functioning groups
Effectiveness at work
    No248.36.3
    Yes1675.65.6 -0.47 0.032

1 –Additional variables tested with non-significant differences in PAID scores–Socio-demographic groups (age, gender. Ethnicity, marital status, education, housing type, income); Clinical groups (diabetes duration); Social functioning groups (effectiveness outside work, family life satisfaction).

2 –oneway ANOVA with Bonferroni corrections when multiple comparisons were made.

1 –Additional variables tested with non-significant differences in PAID scores–Socio-demographic groups (age, gender. Ethnicity, marital status, education, housing type, income); Clinical groups (diabetes duration); Social functioning groups (effectiveness outside work, family life satisfaction). 2 –oneway ANOVA with Bonferroni corrections when multiple comparisons were made.

Discussion

Consistent with the CFA, Rasch analysis revealed that PAID does not measure a single factor among Singaporeans with Type 2 diabetes. This was also reported in other studies. A four-factor solution fit the PAID scale best in a population of US and Dutch patients with diabetes[3], and the Norwegian version[5], while three- and two-factor solutions best fit the Swedish[6] and Icelandic[7] versions. However, if the misfitting items were removed, the 16-item PAID will measure a single latent construct of diabetes-related emotional distress with a minimum score of 0 and maximum score of 16. The advantage of using the Rasch model is that it is an interval scale. Similar to other researchers, we found a high degree of internal consistency [2, 3, 5–7] with the original PAID as well as the 16-item PAID, though there appeared to be a significant floor effect with the 16-item PAID. The scale also showed moderate correlations with other measures having related constructs, indicating reasonable concurrent validity, and were similar to what has been previously reported[3, 5, 21]. The 16-item PAID appeared to be a sensitive instrument, able to distinguish between clinically important groups. We were able to demonstrate a large effect size between those having good versus poor glycemic control. This is in line with existing literature, with weak to moderate correlations reported with HbA1c in cross-sectional studies[2, 5, 7], and small to moderate effect sizes in intervention studies[4]. There is little literature on the sensitivity of PAID with respect to diabetes-related complications, but we have demonstrated that the scale is sensitive to complication status as well. PAID scores did not vary with socio-demographic characteristics except income and housing type, which showed statistically non-significant differences. This demonstrates the instrument’s consistency across various age, ethnic, gender and social groups. As it was not our intention at the outset to reduce the number of items, we conducted further analyses using the original 20-item PAID. The results of the comparison are given in the Appendix (S1 Appendix). The findings were very similar except that there is no floor effect with the original scale and the original scale was able to discriminate between patients with poor and good family life satisfaction. We believe that we have added new information to the literature as this is the first study to apply Rasch analysis to PAID, and this has not been reported previously to our knowledge (based on PubMed search using keywords “PAID” [ti/abs] AND diabetes [ti/abs] AND rasch). Other strengths of our study are a multi-ethnic population of patients and a socio-cultural context where the psychometric properties of PAID have not been previously assessed. We have followed this up with an evaluation of the sensitivity of the instrument to relevant clinical groups, and specifically complications, which have not been reported before. There are also certain limitations, chiefly the cross-sectional nature of the study, which precluded assessment of the test-retest reliability and responsiveness of the instrument, and the inclusion of only English-speaking patients in the study. While this may limit generalizability of our findings, almost 80% of the population is English-literate[31] so the findings will be applicable to the majority. Other factors that may limit study generalizability are the exclusion of older people with diabetes, and disproportionate representation of males (two-thirds) in our sample.

Conclusion

The abridged 16-item PAID measures a single latent trait of emotional distress due to diabetes whereas the 20-item PAID appears to measure more than one latent trait. However, both versions are valid, reliable and sensitive for use among Singaporean patients with diabetes. In fact, the 20-item PAID has slightly better psychometric properties in that it does not exhibit floor effects and can discriminate better. We would recommend keeping to the original 20-item PAID as this would allow for the scores to be compared with other international studies. Clinicians, case managers as well as researchers interested in assessing diabetes-related distress would now have a valid and reliable instrument to use as an outcome measures for interventions in clinical care and research.

Concurrent validity and sensitivity of 20-item PAID.

(DOCX) Click here for additional data file.
  22 in total

1.  The Problem Areas in Diabetes Scale. An evaluation of its clinical utility.

Authors:  G W Welch; A M Jacobson; W H Polonsky
Journal:  Diabetes Care       Date:  1997-05       Impact factor: 19.112

2.  Is the standard SF-12 health survey valid and equivalent for a Chinese population?

Authors:  Cindy L K Lam; Eileen Y Y Tse; Barbara Gandek
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

3.  Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) questionnaire in patients with diabetes in a multi-ethnic Asian country.

Authors:  Hwee-Lin Wee; Chee-Eng Tan; Su-Yen Goh; Shu-Chuen Li
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Diabetes-related emotional distress in adults: reliability and validity of the Norwegian versions of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS).

Authors:  Marit Graue; Anne Haugstvedt; Tore Wentzel-Larsen; Marjolein M Iversen; Bjørg Karlsen; Berit Rokne
Journal:  Int J Nurs Stud       Date:  2011-09-14       Impact factor: 5.837

5.  The psychometric properties of the Swedish version of the Problem Areas in Diabetes Scale (Swe-PAID-20): scale development.

Authors:  Susanne Amsberg; Regina Wredling; Per-Eric Lins; Ulf Adamson; Unn-Britt Johansson
Journal:  Int J Nurs Stud       Date:  2007-11-05       Impact factor: 5.837

6.  Assessment of diabetes-related distress.

Authors:  W H Polonsky; B J Anderson; P A Lohrer; G Welch; A M Jacobson; J E Aponte; C E Schwartz
Journal:  Diabetes Care       Date:  1995-06       Impact factor: 19.112

Review 7.  Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire.

Authors:  G Welch; K Weinger; B Anderson; W H Polonsky
Journal:  Diabet Med       Date:  2003-01       Impact factor: 4.359

Review 8.  Psychological aspects of diabetic neuropathic foot complications: an overview.

Authors:  Loretta Vileikyte; Richard R Rubin; Howard Leventhal
Journal:  Diabetes Metab Res Rev       Date:  2004 May-Jun       Impact factor: 4.876

9.  Validation of the Chinese version of the Problem Areas in Diabetes (PAID-C) scale.

Authors:  Min-Feng Huang; Mary Courtney; Helen Edwards; Jan McDowell
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

10.  Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial.

Authors:  Helen C Eborall; Simon J Griffin; A Toby Prevost; Ann-Louise Kinmonth; David P French; Stephen Sutton
Journal:  BMJ       Date:  2007-08-30
View more
  12 in total

1.  Diabetes distress and peripheral neuropathy are associated with medication non-adherence in individuals with type 2 diabetes in primary care.

Authors:  Zhi Peng Zhang; M Premikha; Miyang Luo; Kavita Venkataraman
Journal:  Acta Diabetol       Date:  2020-11-19       Impact factor: 4.280

2.  Efficacy and Safety of Use of the Fasting Algorithm for Singaporeans With Type 2 Diabetes (FAST) During Ramadan: A Prospective, Multicenter, Randomized Controlled Trial.

Authors:  Zheng Kang Lum; Zi Rui Khoo; Wei Yann See Toh; Shaikh Abdul Kader Kamaldeen; Abdul Shakoor; Keith Yu Kei Tsou; Daniel Ek Kwang Chew; Rinkoo Dalan; Sing Cheer Kwek; Noorani Othman; Joyce Xia Lian; Raden Nurheryany Bte Sunari; Joyce Yu-Chia Lee
Journal:  Ann Fam Med       Date:  2020-03       Impact factor: 5.166

3.  Impact of COVID-19 and partial lockdown on access to care, self-management and psychological well-being among people with diabetes: A cross-sectional study.

Authors:  Ester Yeoh; Soon Guan Tan; Ying Shan Lee; Hwee Huan Tan; Ying Yee Low; Su Chi Lim; Chee Fang Sum; Subramaniam Tavintharan; Hwee Lin Wee
Journal:  Int J Clin Pract       Date:  2021-05-21       Impact factor: 3.149

4.  Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.

Authors:  Leanne V Jones; Amita Ray; Foong Ming Moy; Brian S Buckley
Journal:  Cochrane Database Syst Rev       Date:  2019-05-23

5.  Effects of an Outpatient Diabetes Self-Management Education on Patients with Type 2 Diabetes in China: A Randomized Controlled Trial.

Authors:  Fan Zheng; Suixin Liu; Yuan Liu; Lihua Deng
Journal:  J Diabetes Res       Date:  2019-01-17       Impact factor: 4.011

Review 6.  A Practitioner's Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert Panel.

Authors:  Sanjay Kalra; Sarita Bajaj; Surendra Kumar Sharma; Gagan Priya; Manash P Baruah; Debmalya Sanyal; Sambit Das; Tirthankar Chaudhury; Kalyan Kumar Gangopadhyay; Ashok Kumar Das; Bipin Sethi; Vageesh Ayyar; Shehla Shaikh; Parag Shah; Sushil Jindal; Vaishali Deshmukh; Joel Dave; Aslam Amod; Ansumali Joshi; Sunil Pokharel; Faruque Pathan; Faria Afsana; Indrajit Prasad; Moosa Murad; Soebagijo Adi Soelistijo; Johanes Purwoto; Zanariah Hussein; Lee Chung Horn; Rakesh Sahay; Noel Somasundaram; Charles Antonypillai; Manilka Sumanathilaka; Uditha Bulugahapitiya
Journal:  Diabetes Ther       Date:  2020-01-24       Impact factor: 2.945

7.  Short-term strength and balance training does not improve quality of life but improves functional status in individuals with diabetic peripheral neuropathy: a randomised controlled trial.

Authors:  Kavita Venkataraman; Bee Choo Tai; Eric Y H Khoo; Subramaniam Tavintharan; Kurumbian Chandran; Siew Wai Hwang; Melissa S L A Phua; Hwee Lin Wee; Gerald C H Koh; E Shyong Tai
Journal:  Diabetologia       Date:  2019-08-29       Impact factor: 10.122

8.  Measurement Properties of Patient-Reported Outcome Measures for Diabetes: Systematic Review.

Authors:  Priscilla Jia Ling Wee; Yu Heng Kwan; Dionne Hui Fang Loh; Jie Kie Phang; Troy H Puar; Truls Østbye; Julian Thumboo; Sungwon Yoon; Lian Leng Low
Journal:  J Med Internet Res       Date:  2021-08-13       Impact factor: 5.428

9.  Psychrometric Properties of the Arabic Version of the Problem Areas in Diabetes Scale in Primary Care.

Authors:  Hazem A Sayed Ahmed; Samar Farag Mohamed; Sally Fawzy Elotla; Mona Mostafa; Jaffer Shah; Ahmed Mahmoud Fouad
Journal:  Front Public Health       Date:  2022-02-25

10.  Psychometric properties of the Chinese version of the Problem Areas in Diabetes scale (SG-PAID-C) among high-risk polypharmacy patients with uncontrolled type 2 diabetes in Singapore.

Authors:  Melanie Yee Lee Siaw; Bik-Wai Bilvick Tai; Joyce Yu-Chia Lee
Journal:  J Diabetes Investig       Date:  2016-08-31       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.